Amin Al-Ahmad, MD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Medtronic, INC(SIGNIFICANT), Abbott(SIGNIFICANT), Johnson & Johnson(SIGNIFICANT), BioSig(MODEST), Boston Scientific(SIGNIFICANT), haemonetics(MODEST) EQUITY INTERESTS/STOCK OPTIONS: Myra Vision(SIGNIFICANT), Tioga Medical(MODEST), ESAFE(MODEST), Encompass Vascular(SIGNIFICANT), SoundCath(SIGNIFICANT), Supira Medical(SIGNIFICANT), Akura Medical(SIGNIFICANT), Adona Medical(SIGNIFICANT), LAZA Medical(SIGNIFICANT), DRS Vascular(SIGNIFICANT)

View Full Disclosure